Prescription Doxazosin Tablets Recalled Due to Manufacturing Practice Deviations
Accord Healthcare is recalling 44,068 bottles of Doxazosin 1 mg tablets distributed in the US, Puerto Rico, and Canada due to Current Good Manufacturing Practice deviations found during an FDA inspection.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall based on manufacturing practice compliance violations rather than a demonstrated health hazard. No illnesses, injuries, or hospitalizations are reported. The recall addresses a theoretical quality risk, consistent with voluntary precautionary recalls classified as Moderate.
Plain-English summary
Accord Healthcare, Inc. is recalling 44,068 bottles of Doxazosin 1 mg tablets due to Current Good Manufacturing Practice (CGMP) deviations identified during an FDA inspection. The product, manufactured by Intas Pharmaceuticals Limited, was distributed throughout the United States, Puerto Rico, and Canada.
The affected batches include R2200402, R2200642, R2200643, R2201300, and R2200403, with expiration dates between May 31, 2024, and August 31, 2024. The tablets are supplied in 100-count and 1,000-count bottles (NDC 16729-211-01 and NDC 16729-211-17).
CGMP deviations indicate manufacturing quality defects. Patients currently using this medication should consult their pharmacist or healthcare provider with any questions before discontinuing the medication.
The recalled product
- Product
- DOXAZOSIN (DOXAZOSIN)
- Brand
- DOXAZOSIN
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Prescription Oral Tablet
- Hazard
- manufacturing-deviation
- quality-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Batches: a) R2200402
- Exp. Date 5/31/2024
- R2200642
- R2200643 Exp. Date 8/31/2024
- R2201300 Exp. Date 8/31/2024
- b) R2200403
UPCs (2)
- 316729211017
- 316729211178
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · DOXAZOSIN
- HighPrescription drug recall for manufacturing quality control deviations
FDA (Drugs) · 2023-05-03
- ModerateAccord Healthcare Doxazosin Tablets Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- ModeratePrescription Doxazosin Tablets Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- HighDoxazosin tablets recalled due to manufacturing quality control deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27